Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease.

Hayek SS, Landsittel DP, Wei C, Zeier M, Yu ASL, Torres VE, Roth S, Pao CS, Reiser J.

J Am Soc Nephrol. 2019 Jul;30(7):1305-1313. doi: 10.1681/ASN.2018121227. Epub 2019 Jun 6.

PMID:
31171572
2.

[Real-world effectiveness of ivacaftor in children with cystic fibrosis and the G551D mutation].

Gomez-Pastrana D, Nwokoro C, McLean M, Brown S, Christiansen N, Pao CS.

An Pediatr (Barc). 2019 Mar;90(3):148-156. doi: 10.1016/j.anpedi.2018.05.022. Epub 2018 Aug 6. Spanish.

3.

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases.

Harris PA, Berger SB, Jeong JU, Nagilla R, Bandyopadhyay D, Campobasso N, Capriotti CA, Cox JA, Dare L, Dong X, Eidam PM, Finger JN, Hoffman SJ, Kang J, Kasparcova V, King BW, Lehr R, Lan Y, Leister LK, Lich JD, MacDonald TT, Miller NA, Ouellette MT, Pao CS, Rahman A, Reilly MA, Rendina AR, Rivera EJ, Schaeffer MC, Sehon CA, Singhaus RR, Sun HH, Swift BA, Totoritis RD, Vossenkämper A, Ward P, Wisnoski DD, Zhang D, Marquis RW, Gough PJ, Bertin J.

J Med Chem. 2017 Feb 23;60(4):1247-1261. doi: 10.1021/acs.jmedchem.6b01751. Epub 2017 Feb 10.

PMID:
28151659
4.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O'Brien C, O'Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA.

Science. 2016 Nov 11;354(6313):751-757. doi: 10.1126/science.aaf8156.

5.

DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors.

Harris PA, King BW, Bandyopadhyay D, Berger SB, Campobasso N, Capriotti CA, Cox JA, Dare L, Dong X, Finger JN, Grady LC, Hoffman SJ, Jeong JU, Kang J, Kasparcova V, Lakdawala AS, Lehr R, McNulty DE, Nagilla R, Ouellette MT, Pao CS, Rendina AR, Schaeffer MC, Summerfield JD, Swift BA, Totoritis RD, Ward P, Zhang A, Zhang D, Marquis RW, Bertin J, Gough PJ.

J Med Chem. 2016 Mar 10;59(5):2163-78. doi: 10.1021/acs.jmedchem.5b01898. Epub 2016 Feb 23.

PMID:
26854747
6.

Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis.

Harris PA, Bandyopadhyay D, Berger SB, Campobasso N, Capriotti CA, Cox JA, Dare L, Finger JN, Hoffman SJ, Kahler KM, Lehr R, Lich JD, Nagilla R, Nolte RT, Ouellette MT, Pao CS, Schaeffer MC, Smallwood A, Sun HH, Swift BA, Totoritis RD, Ward P, Marquis RW, Bertin J, Gough PJ.

ACS Med Chem Lett. 2013 Nov 4;4(12):1238-43. doi: 10.1021/ml400382p. eCollection 2013 Dec 12.

7.

Role of the amino terminus of G protein-coupled receptor kinase 2 in receptor phosphorylation.

Pao CS, Barker BL, Benovic JL.

Biochemistry. 2009 Aug 4;48(30):7325-33. doi: 10.1021/bi900408g.

8.

Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages.

Parameswaran N, Pao CS, Leonhard KS, Kang DS, Kratz M, Ley SC, Benovic JL.

J Biol Chem. 2006 Nov 10;281(45):34159-70. Epub 2006 Sep 15.

9.

Lung function tests for pre-school children.

McKenzie SA, Bridge PD, Pao CS.

Paediatr Respir Rev. 2001 Mar;2(1):37-45. Review.

PMID:
16263479
10.

Structure/function analysis of alpha2A-adrenergic receptor interaction with G protein-coupled receptor kinase 2.

Pao CS, Benovic JL.

J Biol Chem. 2005 Mar 25;280(12):11052-8. Epub 2005 Jan 14.

11.

Airway resistance by the interrupter technique: which algorithm for measuring pressure?

Pao CS, Healy MJ, McKenzie SA.

Pediatr Pulmonol. 2004 Jan;37(1):31-6.

PMID:
14679486
12.

Repeatability of airway resistance measurements made using the interrupter technique.

Chan EY, Bridge PD, Dundas I, Pao CS, Healy MJ, McKenzie SA.

Thorax. 2003 Apr;58(4):344-7.

13.

Phosphorylation-independent desensitization of G protein-coupled receptors?

Pao CS, Benovic JL.

Sci STKE. 2002 Oct 8;2002(153):pe42. Review.

PMID:
12372852
14.

Randomized controlled trial of fluticasone in preschool children with intermittent wheeze.

Pao CS, McKenzie SA.

Am J Respir Crit Care Med. 2002 Oct 1;166(7):945-9.

PMID:
12359651
15.

Airway resistance measured by the interrupter technique: normative data for 2-10 year olds of three ethnicities.

McKenzie SA, Chan E, Dundas I, Bridge PD, Pao CS, Mylonopoulou M, Healy MJ.

Arch Dis Child. 2002 Sep;87(3):248-51.

16.

Not all laboratories are alike.

Pao CS, Bridge PD, McKenzie SA.

Eur Respir J. 2001 May;17(5):1054. No abstract available.

17.

Inhaled corticosteroids for persistent wheeze in preschool children.

Pao CS, McKenzie SA.

Am J Respir Crit Care Med. 2001 Apr;163(5):1278. No abstract available.

PMID:
11316670

Supplemental Content

Support Center